Glaxosmithkline Plc Theravance Biopharma, Inc. (TBPH) insider trading activity

TBPH Quotes by TradingView

GLAXOSMITHKLINE PLC Transaction History

Date Transaction Value Shares Traded Form
Sep 16 2022
SELL
Other acquisition or disposition
$94,036,868 $9.75 p/Share
9,644,807

Also insider at

TPTX
Turning Point Therapeutics, Inc.
Director
CRSP
CRISPR Therapeutics AG Healthcare
> 10% Shareholder
PGNY
Progyny, Inc. Healthcare
> 10% Shareholder
CCXI
ChemoCentryx, Inc.
LYEL
Lyell Immunopharma, Inc. Healthcare
> 10% Shareholder
INVA
Innoviva, Inc. Healthcare
> 10% Shareholder
MORF
Morphic Holding, Inc. Healthcare
Director
BCYC
BICYCLE THERAPEUTICS plc Healthcare
> 10% Shareholder
NKTX
Nkarta, Inc. Healthcare
Director
FULC
Fulcrum Therapeutics, Inc. Healthcare
WVE
Wave Life Sciences Ltd. Healthcare
> 10% Shareholder
CVRX
CVRx, Inc. Healthcare
> 10% Shareholder
DBTX
Decibel Therapeutics, Inc. Healthcare
Director
SPRO
Spero Therapeutics, Inc. Healthcare
> 10% Shareholder
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
> 10% Shareholder
TBIO
Translate Bio, Inc. Healthcare
> 10% Shareholder
PAND
Pandion Therapeutics, Inc.
Director
PRNB
Principia Biopharma Inc.
LQDA
Liquidia Technologies Inc
GP

Glaxosmithkline PLC

Brentford Middlesex, X0

Track Institutional and Insider Activities on TBPH

Follow Theravance Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

News

Receive news related to Theravance Biopharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TBPH